Cyanidin 3-glucoside and peonidin 3-glucoside inhibit tumor cell growth and induce apoptosis in vitro and suppress tumor growth in vivo

Nutrition and Cancer

Volumn 53, Issue 2, 2005, Pages 232-243

  Chen, Pei Ni ^a,b   Chu, Shu Chen ^b   Chiou, Hui Ling ^a   Chiang, Chui Liang ^b   Yang, Shun Fa ^a   Hsieh, Yih Shou ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHOCYANIN; CASPASE 3; CYANIDIN 3 GLUCOSIDE; CYCLIN B1; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 2; CYCLIN E; PEONIDIN 3 GLUCOSIDE; POLYPHENOL; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL DEATH; CHROMATIN CONDENSATION; CONTROLLED STUDY; ENZYME ACTIVATION; FRUIT; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEWIS CARCINOMA; MALE; MOUSE; NONHUMAN; RICE; VEGETABLE;

ANIMALS; ANTHOCYANINS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, LEWIS LUNG; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSIDES; HUMANS; MALE; MICE; MICE, INBRED C57BL; NEOPLASMS; ORYZA SATIVA; TIME FACTORS;

ANIMALIA; ORYZA;

EID: 33645902167     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15327914nc5302_12     Document Type: Article

References (36)

1. Grana X and Reddy EP: Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 11, 211-219, 1995.
2. Swanton C: Cell-cycle targeted therapies. Lancet Oncol 5, 27-36, 2004.
3. MacLachlan TK, Sang N, and Giordano A: Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer. Crit Rev Eukaryot Gene Expr 5, 127-156, 1995.
4. Steller H: Mechanisms and genes of cellular suicide. Science 267, 1445-1449, 1995.
5. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, and Earnshaw WC: Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371, 346-347, 1994.
6. Pezzuto JM: Plant-derived anticancer agents. Biochem Pharmacol 53, 121-133, 1997.
7. Fakih M, Yagoda A, Replogle T, Lehr JE, and Pienta KJ: Inhibition of prostate cancer growth by estramustine and colchicine. Prostate 26, 310-315, 1995.
8. Brown DM, Kelly GE, and Husband AJ: Flavonoid compounds in maintenance of prostate health and prevention and treatment of cancer. Mol Biotechnol 30, 253-270, 2005.
9. Xu Z, Hua N, and Godber JS: Antioxidant activity of tocopherols, tocotrienols, and gamma-oryzanol components from rice bran against cholesterol oxidation accelerated by 2,2′-azobis(2-methyl-propionamidine) dihydrochloride. J Agric Food Chem 49, 2077-2081, 2001.
10. Sugano M and Tsuji E: Rice bran oil and cholesterol metabolism. J Nutr 127, S521-S524, 1997.
11. Ling WH, Cheng QX, Ma J, and Wang T: Red and black rice decrease atherosclerotic plaque formation and increase antioxidant status in rabbits. J Nutr 131, 1421-1426, 2001.
12. Xia M, Ling WH, Ma J, Kitts DD, and Zawistowski J: Supplementation of diets with the black rice pigment fraction attenuates atherosclerotic plaque formation in apolipoprotein e deficient mice. J Nutr 133, 744-751, 2003.
13. Hu C, Zawistowski J, Ling W, and Kitts DD: Black rice (Oryza saliva L. indica) pigmented fraction suppresses both reactive oxygen species and nitric oxide in chemical and biological model systems. J Agric Food Chem 51, 5271-5277, 2003.
14. Hyun JW and Chung HS: Cyanidin and malvidin from Oryza saliva cv. Heugjinjubyeo mediate cytotoxicity against human monocytic leukemia cells by arrest of G(2)/M phase and induction of apoptosis. J Agric Food Chem 52, 2213-2217, 2004.
15. Chen PN, Chu SC, Chiou HL, Kuo WH, Chiang CL, et al.: Mulberry anthocyanins, cyanidin 3-rutinoside and cyanidin 3-glucoside, exhibited an inhibitory effect on the migration and invasion of a human lung cancer cell line. Cancer Lett 2006 (in press).
16. Singh RP, Tyagi AK, Zhao J, and Agarwal R: Silymarin inhibits growth and causes regression of established skin tumors in SENCAR mice via modulation of mitogen-activated protein kinases and induction of apoptosis. Carcinogenesis 23, 499-510, 2002.
17. Lai Y, Tse CM, and Unadkat JD: Mitochondrial expression of the human equilibrative nucleoside transporter 1 (hENT1) results in enhanced mitochondrial toxicity of antiviral drugs. J Biol Chem 279, 4490-4497, 2004.
18. Chiang WL, Chu SC, Yang SS, Li MC, Lai JC, et al.: The aberrant expression of cytosolic carbonic anhydrase and its clinical significance in human non-small cell lung cancer. Cancer Lett 188, 199-205, 2002.
19. Zi X, Grasso AW, Kung HJ, and Agarwal R: A flavonoid antioxidant, silymarin, inhibits activation of erbB1 signaling and induces cyclin-dependent kinase inhibitors, G1 arrest, and anticarcinogenic effects in human prostate carcinoma DU145 cells. Cancer Res 58, 1920-1929, 1998.
20. Cazillis M, Bringuier AF, Delautier D, Buisine M, Bernuau D, et al.: Disruption of MKK4 signaling reveals its tumor-suppressor role in embryonic stem cells. Oncogene 23, 4735-4744, 2004.
21. Sigounas G, Sallah S, and Sigounas VY: Erythropoietin modulates the anticancer activity of chemotherapeutic drugs in a murine lung cancer model. Cancer Lett 214, 171-179, 2004.
22. Kelloff GJ: Perspectives on cancer chemoprevention research and drug development. Adv Cancer Res 78, 199-334, 2000.
23. Katsuzaki H, Hibasami H, Ohwaki S, Ishikawa K, Imai K, et al.: Cyanidin 3-O-beta-D-glucoside isolated from skin of black Glycine max and other anthocyanins isolated from skin of red grape induce apoptosis in human lymphoid leukemia Molt 4B cells. Oncol Rep 10, 297-300, 2003.
24. Katsube N, Iwashita K, Tsushida T, Yamaki K, and Kobori M: Induction of apoptosis in cancer cells by Bilberry (Vaccinium myrtillus) and the anthocyanins. J Agric Food Chem 51, 68-75, 2003.
25. Bagchi D, Sen CK, Bagchi M, and Atalay M: Anti-angiogenic, antioxidant, and anti-carcinogenic properties of a novel anthocyanin-rich berry extract formula. Biochemistry (Moscow) 69, 75-80, 2004.
26. Liu M, Li XQ, Weber C, Lee CY, Brown J, et al.: Antioxidant and antiproliferative activities of raspberries. J Agric Food Chem 50, 2926-2930, 2002.
27. Elledge SJ and Harper JW: Cdk inhibitors: on the threshold of checkpoints and development. Curr Opin Cell Biol 6, 847-852, 1994.
28. Sherr CJ: G1 phase progression: cycling on cue. Cell 79, 551-555, 1994.
29. Abal M, Bras-Goncalves R, Judde JG, Fsihi H, De Cremoux P, et al.: Enhanced sensitivity to irinotecan by Cdk1 inhibition in the p53-deficient HT29 human colon cancer cell line. Oncogene 23, 1737-1744, 2004.
30. Singh SV, Herman-Antosiewicz A, Singh AV, Lew KL, Srivastava SK, et al.: Sulforaphane-induced G2/M phase cell cycle arrest involves checkpoint kinase 2-mediated phosphorylation of cell division cycle 25C. J Biol Chem 279, 25813-25822, 2004.
31. Stumm S, Meyer A, Lindner M, Bastert G, Wallwiener D, et al.: Paclitaxel treatment of breast cancer cell lines modulates Fas/Fas ligand expression and induces apoptosis which can be inhibited through the CD40 receptor. Oncology 66, 101-111, 2004.
32. Hou DX, Kai K, Li JJ, Lin S, Terahara N, et al.: Anthocyanidins inhibit activator protein 1 activity and cell transformation: structure-activity relationship and molecular mechanisms. Carcinogenesis 25, 29-36, 2004.
33. Raghavan D, Koczwara B, and Javle M: Evolving strategies of cytotoxic chemotherapy for advanced prostate cancer. Eur J Cancer 33, 566-574, 1997.
34. Von Hoff DD, Layard MW, Basa P, Davis HL Jr, Von Hoff AL, et al.: Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 91, 710-717, 1979.
35. Tyagi AK, Agarwal C, Chan DC, and Agarwal R: Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells. Oncol Rep 11, 493-499, 2004.
36. Matsumoto H, Inaba H, Kishi M, Tominaga S, Hirayama M, et al.: Orally administered delphinidin 3-rutinoside and cyanidin 3-rutinoside are directly absorbed in rats and humans and appear in the blood as the intact forms. J Agric Food Chem 49, 1546-1551, 2001.